160 related articles for article (PubMed ID: 29973377)
21. Nonfunctioning pituitary adenomas: association of Ki-67 and HMGA-1 labeling indices with residual tumor growth.
Šteňo A; Bocko J; Rychlý B; Chorváth M; Celec P; Fabian M; Belan V; Šteňo J
Acta Neurochir (Wien); 2014 Mar; 156(3):451-61; discussion 461. PubMed ID: 24452592
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors of postoperative diabetes insipidus in 333 patients undergoing transsphenoidal surgery for non-functioning pituitary adenoma.
Kinoshita Y; Taguchi A; Tominaga A; Sakoguchi T; Arita K; Yamasaki F
Pituitary; 2022 Feb; 25(1):100-107. PubMed ID: 34283369
[TBL] [Abstract][Full Text] [Related]
23. Prediction of pituitary adenoma surgical consistency: radiomic data mining and machine learning on T2-weighted MRI.
Cuocolo R; Ugga L; Solari D; Corvino S; D'Amico A; Russo D; Cappabianca P; Cavallo LM; Elefante A
Neuroradiology; 2020 Dec; 62(12):1649-1656. PubMed ID: 32705290
[TBL] [Abstract][Full Text] [Related]
24. Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery.
Dubois S; Guyétant S; Menei P; Rodien P; Illouz F; Vielle B; Rohmer V
Eur J Endocrinol; 2007 Aug; 157(2):141-7. PubMed ID: 17656591
[TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma.
Kremer P; Forsting M; Ranaei G; Wüster C; Hamer J; Sartor K; Kunze S
Acta Neurochir (Wien); 2002 May; 144(5):433-43. PubMed ID: 12111499
[TBL] [Abstract][Full Text] [Related]
26. [Controlled pathological study and preoperative MRI evaluation of the consistency of pituitary adenomas].
Yang C; Zhang H; Wang HJ; Chen MZ; He DS; Ke CL
Ai Zheng; 2002 Jun; 21(6):675-7. PubMed ID: 12452074
[TBL] [Abstract][Full Text] [Related]
27. Tumor shrinkage after transsphenoidal surgery for nonfunctioning pituitary adenoma.
Berkmann S; Schlaffer S; Buchfelder M
J Neurosurg; 2013 Dec; 119(6):1447-52. PubMed ID: 24074495
[TBL] [Abstract][Full Text] [Related]
28. Solid tumor size for prediction of recurrence in large and giant non-functioning pituitary adenomas.
Ko CC; Chang CH; Chen TY; Lim SW; Wu TC; Chen JH; Kuo YT
Neurosurg Rev; 2022 Apr; 45(2):1401-1411. PubMed ID: 34606021
[TBL] [Abstract][Full Text] [Related]
29. Increased β‑catenin and c-myc expression predict aggressive growth of non-functioning pituitary adenomas: An assessment using a tissue microarray-based approach.
Liu C; Wu Y; Yu S; Bai J; Li C; Wu D; Zhang Y
Mol Med Rep; 2017 Apr; 15(4):1793-1799. PubMed ID: 28260015
[TBL] [Abstract][Full Text] [Related]
30. Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma.
Berkmann S; Schlaffer S; Nimsky C; Fahlbusch R; Buchfelder M
J Neurosurg; 2014 Nov; 121(5):1166-75. PubMed ID: 25127413
[TBL] [Abstract][Full Text] [Related]
31. Radiologic Predictors for Extent of Resection in Pituitary Adenoma Surgery. A Single-Center Study.
Sanmillán JL; Torres-Diaz A; Sanchez-Fernández JJ; Lau R; Ciller C; Puyalto P; Gabarrós A
World Neurosurg; 2017 Dec; 108():436-446. PubMed ID: 28899832
[TBL] [Abstract][Full Text] [Related]
32. Discrimination between pituitary adenoma and craniopharyngioma using MRI-based image features and texture features.
Zhang Y; Chen C; Tian Z; Xu J
Jpn J Radiol; 2020 Dec; 38(12):1125-1134. PubMed ID: 32710133
[TBL] [Abstract][Full Text] [Related]
33. Nonfunctioning pituitary adenomas in elderly patients.
Kinoshita Y; Kurisu K; Arita K
J Clin Neurosci; 2018 Jul; 53():127-131. PubMed ID: 29739724
[TBL] [Abstract][Full Text] [Related]
34. Tumor T2 signal intensity and stalk angulation correlates with endocrine status in pituitary adenoma patients: a quantitative 7 tesla MRI study.
Rutland JW; Pawha P; Belani P; Delman BN; Gill CM; Brown T; Cheesman K; Shrivastava RK; Balchandani P
Neuroradiology; 2020 Apr; 62(4):473-482. PubMed ID: 31925468
[TBL] [Abstract][Full Text] [Related]
35. The Likelihood of Remnant Nonfunctioning Pituitary Adenomas Shrinking Is Associated with the Lesion's Blood Supply Pattern.
Ito M; Kuge A; Matsuda KI; Sato S; Kayama T; Sonoda Y
World Neurosurg; 2017 Nov; 107():137-141. PubMed ID: 28780404
[TBL] [Abstract][Full Text] [Related]
36. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
37. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.
Juraschka K; Khan OH; Godoy BL; Monsalves E; Kilian A; Krischek B; Ghare A; Vescan A; Gentili F; Zadeh G
J Neurosurg; 2014 Jul; 121(1):75-83. PubMed ID: 24785323
[TBL] [Abstract][Full Text] [Related]
38. Is Positive Staining of Non-Functioning Pituitary Adenomas for Luteinizing Hormone Associated with a Poor Prognosis?
Diri H; Ozaslan E; Kurtsoy A; Tucer B; Simsek Y; Ozturk F; Durak AC; Erten S; Bayram F
Turk Neurosurg; 2017; 27(1):8-13. PubMed ID: 27593756
[TBL] [Abstract][Full Text] [Related]
39. Is it really possible to predict the consistency of a pituitary adenoma preoperatively?
Thotakura AK; Patibandla MR; Panigrahi MK; Mahadevan A
Neurochirurgie; 2017 Dec; 63(6):453-457. PubMed ID: 29122303
[TBL] [Abstract][Full Text] [Related]
40. The Value of Intraoperative Magnetic Resonance Imaging in Endoscopic and Microsurgical Transsphenoidal Pituitary Adenoma Resection.
Pal'a A; Knoll A; Brand C; Etzrodt-Walter G; Coburger J; Wirtz CR; Hlaváč M
World Neurosurg; 2017 Jun; 102():144-150. PubMed ID: 28286276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
